Randal W. Scott, CEO, In Vitae Corporation* at GENOMIC HEALTH INC (GHDX), sold 30,000 shares at $30.00 ($907K) on 2012-05-11, disclosed to the SEC on 2012-05-14.
Scheduled sale ($907k) by CEO, In Vitae Corporation* under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.92 | 14,600 | $437K | 48.2% |
| 2 | $30.29 | 400 | $12K | 1.3% |
| 3 | $30.00 | 7,200 | $216K | 23.8% |
| 4 | $30.85 | 5,620 | $173K | 19.1% |
| 5 | $31.39 | 2,180 | $68K | 7.5% |
| Total | $30.23 avg | 30,000 |
| $907K |
| 100% |
| Filing → |
| NVTA | SELL | 2019-02-27 | $573K | — | Filing → |
| NVTA | BUY | 2018-04-02 | $200K | — | Filing → |
| NVTA | BUY | 2016-11-22 | $400K | — | Filing → |